Abstract:Background: Ventricular septal defect (VSD) is the most common congenital cardiac malformation, accounting for approximately 30% of congenital heart defects. Conventional surgical repair using cardiopulmonary bypass is invasive and associated with morbidities and prolonged hospital stay. With the advent of interventional approaches and availability of different occluding devices, the technique of perventricular device closure is evolving and being implemented successfully in larger groups of patients. We present herein, our initial experience of perventricular device closure for the ventricular septal defects in children to assess risks and benefits. Methods: From March, 2023 to February, 2024, we have performed perventricular closure of ventricular septal defects in 13 children, under guidance of transesophageal echocardiography without cardiopulmonary bypass support. The median age at operation was 2 year (range 1.3-10 years) with the median body weight 11 kg (range 8.7-16.6 kg). Sixty-nine percent were males. The ventricular septal defect sizes ranged from 2.7 to 6 mm (mean 4.7 mm). Seven defects were perimembranous, four sub-aortic and two were muscular. One patient also underwent pulmonary artery de-banding with pulmonary artery balloon angioplasty and other one patent ductus arteriosus ligation, concomitantly. For defect closure, we used ventricular septal defect occlusion device (MemoPart™, Lepu Medical Technology Company, China) through a 3-cm skin incision in the lower- third of the sternum. The device sizes ranged from 5 to 8 mm (mean 6.9+-1.8 mm) and all patients except for two required symmetrical devices. Results: All patients underwent device closure successfully. The procedural duration ranged between 32 and 52 min. None of the patients required cardiopulmonary bypass. The mean ventilation time and intensive care unit stay was 3 and 24 h, respectively. None of the patients required inotropic support or blood transfusions. Moreover, no patients developed any arrhythmias including heart block. The average length of hospital stay was 4.4 days. At the latest follow up, there were no residual shunts, conduction disturbances, device dislodgement or major aortic or tricuspid valve complications seen in any patients. There was no mortality. Conclusions: Perventricular device closure of ventricular septal defects is a less invasive, extremely safe and effective method in children. It is associated with very fast recovery, shorter hospitalization time and better cosmetic incision. Moreover, it avoids cardiopulmonary bypass. The modifications and refinements in the design, material and implantation techniques will help in expanding the indications and prevent complications in the long-term.

Complete atrioventricular block after atrial flow regulator implantation in a 5 kg infant

Atrial flow regulator in transposition of the great arteries, ventricular septal defect, and pulmonary stenosis: a case report

Feasibility, Safety, and Efficacy of the Atrial Flow Regulator in Pediatric Patients: A Single-Center Experience

Implantation of atrial flow regulator devices in patients with congenital heart disease and children with severe pulmonary hypertension or cardiomyopathy—an international multicenter case series

Stent Implantation Across the Atrial Flow Regulator Device

Late complete atrioventricular block after transcatheter perimembranous ventricular septal defect closure with the KONAR-MFTM VSD occluder: a case report and systematic review

Word of caution: silent late device embolisation after perimembranous ventricular septal defect closure in a 6-Kg infant

Perventricular device closure of the ventricular septal defects in children-first experience in the United Arab Emirates

Perinatal management of neonatal congenital complete atrioventricular block: a survey of 5 cases

Postoperative Atrioventricular Block in Pediatric Patients: Impact of Congenital Cardiac Malformations and Medications

Dual-chamber leadless pacemaker in complex adult congenital heart disease: a case report

Early and delayed atrioventricular conduction block after routine surgery for congenital heart disease

Permanent Left Bundle Branch Area Pacing for High-Degree Atrioventricular Block in a 6-Year-old Child with 2-Year Follow-Up

Interventional Closure of Secundum Type Atrial Septal Defects in Infants Less Than 10 Kilograms: Indications and Procedural Outcome

Atrial leadless pacemaker implant using Aveir VR in an adolescent with congenital heart disease

Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II

Incidence and Outcomes of Iatrogenic Complete Atrioventricular Block After Congenital Heart Surgery

Postoperative catheter thrombaspiration to open an occluded right ventricle-to-pulmonary artery conduit in child

Safety and feasibility of transcatheter closure of atrial septal defects in small children weighing less than 10 kg

Atrioventricular node ablation and the pathological findings of a refractory ectopic atrial tachycardia in a small infant with hypoplastic left heart syndrome: a case report

Transcatheter closure of main pulmonary artery pseudoaneurysm using atrial septal occluder device in an infant